Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a -11.847\% hERG inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a: CCC(=O)OC1(c2cccc(C)c2)CC(C)N(C)CC1C.Cl
b: Cc1csc(=O)n1CCC(=O)OCc1nnc(-c2ccccc2)o1
c: Cc1cc(=O)oc2cc(OC(C)C(=O)NC3(C#N)CCCCC3)ccc12
d: O=C(CN1C2CCCC1CC(NC(=O)c1ccccc1)C2)Nc1nccs1
Answer: d. O=C(CN1C2CCCC1CC(NC(=O)c1ccccc1)C2)Nc1nccs1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CN1C2CCCC1CC(NC(=O)c1ccccc1)C2)Nc1nccs1
O=C(CN1C2CCCC1CC(NC(=O)c1ccccc1)C2)Nc1nccs1
N-[9-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-9-azabicyclo[3.3.1]nonan-3-yl]benzamide